Rui Benfeitas
Rui Benfeitas
NBIS - National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Stockholm
Verified email at - Homepage
TitleCited byYear
A pathology atlas of the human cancer transcriptome
M Uhlen, C Zhang, S Lee, E Sjöstedt, L Fagerberg, G Bidkhori, ...
Science 357 (6352), eaan2507, 2017
Hydrogen peroxide metabolism and sensing in human erythrocytes: a validated kinetic model and reappraisal of the role of peroxiredoxin II
R Benfeitas, G Selvaggio, F Antunes, PMBM Coelho, A Salvador
Free Radical Biology and Medicine 74, 35-49, 2014
New challenges to study heterogeneity in cancer redox metabolism
R Benfeitas, M Uhlen, J Nielsen, A Mardinoglu
Frontiers in cell and developmental biology 5, 65, 2017
TCSBN: a database of tissue and cancer specific biological networks
S Lee, C Zhang, M Arif, Z Liu, R Benfeitas, G Bidkhori, S Deshmukh, ...
Nucleic acids research 46 (D1), D595-D600, 2017
Metabolic network-based identification and prioritization of anti-cancer targets based on expression data in hepatocellular carcinoma
G Bidkhori, R Benfeitas, E Elmas, M Naeimi Kararoudi, M Arif, M Uhlen, ...
Frontiers in physiology 9, 916, 2018
Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes
G Bidkhori, R Benfeitas, M Klevstig, C Zhang, J Nielsen, M Uhlen, J Boren, ...
Proceedings of the National Academy of Sciences 115 (50), E11874-E11883, 2018
Understanding the representative gut microbiota dysbiosis in metformin-treated type 2 diabetes patients using genome-scale metabolic modeling
D Rosario, R Benfeitas, G Bidkhori, C Zhang, M Uhlen, S Shoaie, ...
Frontiers in physiology 9, 775, 2018
A pathology atlas of the human cancer transcriptome. Science 357: eaan2507
M Uhlen, C Zhang, S Lee, E Sjöstedt, L Fagerberg, G Bidkhori, ...
Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis
R Benfeitas, G Bidkhori, B Mukhopadhyay, M Klevstig, M Arif, C Zhang, ...
EBioMedicine 40, 471-487, 2019
Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome
A Lovric, M Granér, E Bjornson, M Arif, R Benfeitas, K Nyman, M Ståhlman, ...
Scientific Reports 8 (1), 14200, 2018
Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
B Turanli, C Zhang, W Kim, R Benfeitas, M Uhlen, KY Arga, A Mardinoglu
EBioMedicine 42, 386-396, 2019
Identification of line‐specific strategies for improving carotenoid production in synthetic maize through data‐driven mathematical modeling
J Comas, R Benfeitas, E Vilaprinyo, A Sorribas, F Solsona, G Farré, ...
The Plant Journal 87 (5), 455-471, 2016
ESS: a tool for genome-scale quantification of essentiality score for reaction/genes in constraint-based modeling
C Zhang, S Lee, R Benfeitas, G Bidkhori, M Arif, A Mardinoglu
Frontiers in physiology 9, 1355, 2018
Is the Peroxiredoxin 2/Thioredoxin/Thioredoxin Reductase system in human erythrocytes designed for redox signaling?
R Benfeitas, G Selvaggio, F Antunes, P Coelho, A Salvador
Free Radical Biology and Medicine 75, S24, 2014
RMetD2: a tool for integration of relative transcriptomics data into Genome-scale metabolic models
C Zhang, S Lee, G Bidkhori, R Benfeitas, A Lovric, S Chen, M Uhlen, ...
BioRxiv, 663096, 2019
Prostate cancer spesific metabolic model as tool for drug repositioning
B Turanlı, A Lovric, R Benfeitas, G Bidkhori, C Zhang, KY Arga, ...
Book of Abstracts, 80, 0
The system can't perform the operation now. Try again later.
Articles 1–16